Measurable Brain Metastases

Ian E. Krop, MD, PhD, associate chief of the division of breast oncology in the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute, spoke with Healio about recent findings from the DESTINY-Breast03 trial.